A 42-year-old woman with myasthenia gravis (MG) undergoes laparoscopic cholecystectomy. Anesthesia is induced with propofol and remifentanil; succinylcholine is avoided. Rocuronium 0.6 mg/kg is given for intubation. Intraoperatively, train-of-four monitoring shows progressive fade (TOF ratio 0.4 at 90 minutes). The surgeon requests one more 15-minute interval for hemostasis. What is the most appropriate management?

Explanation

## Clinical Context This patient has myasthenia gravis, a neuromuscular junction disorder characterized by antibodies against nicotinic acetylcholine receptors. She has received rocuronium and now shows moderate neuromuscular blockade (TOF ratio 0.4) with 15 minutes of surgery remaining. ## Why Sugammadex Is Correct **Key Point:** In patients with myasthenia gravis, neuromuscular blockers have unpredictable and prolonged effects. Sugammadex provides rapid, reliable reversal independent of the underlying neuromuscular pathology. **High-Yield:** Sugammadex is preferred in MG because: 1. **Encapsulation mechanism** — does not rely on acetylcholine receptor function (which is defective in MG) 2. **Rapid and complete reversal** — restores neuromuscular function reliably 3. **Allows re-dosing** — if additional blockade is needed, rocuronium can be re-administered after sugammadex reversal 4. **Avoids cholinergic agents** — neostigmine can precipitate cholinergic crisis in MG patients **Clinical Pearl:** Patients with MG are exquisitely sensitive to neuromuscular blockers and have unpredictable recovery. Rocuronium duration is prolonged; spontaneous recovery is unreliable. Sugammadex reversal at this point (TOF 0.4) followed by re-dosing if needed is the safest approach. ## Neuromuscular Management in MG | Scenario | Approach | Rationale | |----------|----------|----------| | **Induction in MG** | Avoid succinylcholine; use rocuronium (onset slower but more predictable) | Succinylcholine causes prolonged apnea in MG; rocuronium is safer | | **Intraoperative monitoring** | Mandatory TOF monitoring; expect prolonged blockade | Neuromuscular junction dysfunction makes standard dosing unreliable | | **Reversal in MG** | **Sugammadex preferred**; avoid neostigmine | Neostigmine can worsen MG symptoms and cause cholinergic crisis | | **If spontaneous recovery needed** | Allow extended time; monitor continuously | Recovery is slow and unpredictable | **Warning:** ~~Neostigmine~~ is contraindicated in acute MG exacerbation and should be avoided perioperatively. It can precipitate cholinergic crisis (excessive salivation, bronchospasm, bradycardia, weakness). ## Decision Algorithm ```mermaid flowchart TD A[Patient with MG<br/>Intraoperative Rocuronium]:::outcome --> B{TOF Ratio & Time Remaining?}:::decision B -->|TOF 0.4, 15 min remaining| C[Sugammadex 2 mg/kg]:::action B -->|TOF < 0.2, need more time| D[Sugammadex 2 mg/kg]:::action C --> E[Rapid Reversal<br/>TOF Ratio > 0.9]:::outcome D --> E E --> F{More Blockade Needed?}:::decision F -->|Yes| G[Re-dose Rocuronium<br/>0.1-0.15 mg/kg]:::action F -->|No| H[Proceed to Closure<br/>Monitor for Recovery]:::action I[Neostigmine]:::urgent --> J[CONTRAINDICATED in MG<br/>Risk: Cholinergic Crisis]:::urgent K[Spontaneous Recovery]:::action --> L[Unpredictable & Prolonged<br/>in MG]:::outcome ``` ## Why Sugammadex Over Alternatives **Mnemonic: SAFE reversal in MG = Sugammadex Avoids Failure & cholinErgic crisis** - **S**ugammadex: encapsulation, independent of NMJ pathology - **A**voids: neostigmine (cholinergic risk) - **F**ast: 3–5 minutes to TOF > 0.9 - **E**ffective: re-dosing possible if needed [cite:Barash et al. Clinical Anesthesia 8e Ch 12; Morgan & Mikhail 6e Ch 11]